B-type natriuretic peptide and outcome in patients with apical hypertrophic cardiomyopathy
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Journal of Cardiology
- Vol. 76 (4) , 357-363
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2013
- Tissue Doppler Imaging and Plasma BNP Levels to Assess the Prognosis in Patients with Hypertrophic CardiomyopathyJournal of the American Society of Echocardiography, 2011
- Clinical Implications of Midventricular Obstruction in Patients With Hypertrophic CardiomyopathyJACC, 2011
- Clinical Profiles of Hypertrophic Cardiomyopathy With Apical Phenotype Comparison of Pure-Apical Form and Distal-Dominant FormCirculation Journal, 2009
- Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic CardiomyopathyCirculation, 2008
- Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2007
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic CardiomyopathyCirculation, 2004
- Long-term outcome in patients with apical hypertrophic cardiomyopathyJACC, 2002
- Giant T Wave Inversion as a Manifestation of Asymmetrical Apical Hypertrophy (AAH) of the Left VentricleJapanese Heart Journal, 1976